Researchers in the field of psychedelics hit the ground running at the turn of the new year. January brought with it the largest published clinical trial with psilocybin to date. While ketamine was shown to be effective in treating patients with alcohol use disorder, the same can’t be said for PTSD. A host of reviews provide food for thought on a range of psychedelics and their mechanism of action.
How do we make psychedelics available for research and therapy? We spoke to Berra Yazar-Klosinski to learn about how MAPS PBC is making cGMP MDMA at scale.
Psychedelics are poised to be a paradigm shift in mental healthcare but will this paradigm shift have a truly global impact? Here we discuss some reasons why this is unlikely.
A change in policy surrounding psychedelics is needed. Here we discuss the barriers to change and how they might be overcome.
In the Research Briefing of January 24th: 1) Ketamine effective in abstaining from alcohol for up to 6 months later 2) Real-world data provides further evidence ketamine therapy is effective for depression 3) But a large study finds ketamine not to be effective for PTSD in service members
Integration of psychedelic experiences can be key | How the integration after psychedelics can be vital for positive therapeutic outcomes
From drug policy reform to virtual reality, psychedelics are entering the 21st century | Guest post for Drugs&Me
In the Research Briefing of January 10th: 1) Psilocybin can be administered safely for up to six people simultaneously 2) An Open Science approach toward MDMA synthesis 3) Nitrous Oxide could be the next antidepressant
This is all the other psychedelic research that came out in January 2022.
December was another busy month in the world of psychedelic research as 2021 came to a close. The benefits of microdosing remain in dispute, the use of virtuality reality in tandem with psychedelics is further discussed, while we simultaneously gained further insight as to how different psychedelics work in the brain for different disorders, through both experiments and reviews.